New drug cocktail targets aggressive breast cancer
Disease control
Ongoing
This study tests a combination of two targeted drugs, tucatinib and alpelisib, in people with a specific genetic mutation (PIK3CA) and HER2-positive advanced breast cancer. About 40 adults whose cancer has spread or cannot be removed will take these pills daily. The goal is to se…
Phase: PHASE1, PHASE2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC